TENX Stock Predictions
| Recent TENX Stock Price | TENX Stock Predictions | |
| $5.77 |  +281.28% |
$22.00 |
| Recent TENX Analyst Ratings Breakdown, Making TENX Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 4 | 4 | 4 | 4 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the TENX stock predictions from the analysts covering Tenax Therapeutics Inc, we have collected all of the individual TENX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering TENX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TENX stock predictions may vary widely, another useful metric to consider is the median TENX stock prediction, which represents the price at which half of the analysts
made TENX stock predictions that were higher and half made TENX stock predictions that were lower. This makes for a different take on the TENX stock predictions out there, as compared to average or mean.
And that median across all the individual TENX stock predictions was: $20.0 as of 2025-04-25.
The very highest of the TENX stock predictions for one year price target was $30.0, while the very lowest of the TENX stock predictions in the analyst group was
$16.0 (with a standard deviation of $7.211). Get the latest Zacks research report on TENX — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• HBIO Stock Predictions
• VC Stock Predictions
• FUL Stock Predictions
• MCK Stock Predictions
• TD Stock Predictions
• FRBK Stock Predictions
• PLOW Stock Predictions
• FMC Stock Predictions
• CBRL Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free TENX Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 81st percentile
(ranked higher than approx. 81% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
